New maintenance treatment for acute myeloid leukemia prolongs the lives of patients ...Middle East

- News
New maintenance treatment for acute myeloid leukemia prolongs the lives of patients
Patients with acute myeloid leukemia (AML), the most common form of acute leukemia in adults, that has gone into remission following initial chemotherapy remain in remission longer and have improved overall survival when they are given a pill form of the cancer drug azacitidine as a maintenance treatment, according to a randomized, international phase 3 clinical trial for which Weill Cornell Medicine and NewYork-Presbyterian are trial sites.

Hence then, the article about new maintenance treatment for acute myeloid leukemia prolongs the lives of patients was published today ( ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( New maintenance treatment for acute myeloid leukemia prolongs the lives of patients )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News